Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.

about

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

P2860

Q55016620-D6AE74DB-EE14-4181-993F-B5DB1E384FF5 Q55476982-829FD46E-9B75-4407-A931-DFB76039C003

P2860

Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.

Item

http://www.wikidata.org/entity/Q54912272

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Two phosphAte taRGets in End-s ...... A Randomized Controlled Trial.

@en

Two phosphAte taRGets in End-stage renal disease Trial

@nl

type

Item

label

Two phosphAte taRGets in End-s ...... A Randomized Controlled Trial.

@en

Two phosphAte taRGets in End-stage renal disease Trial

@nl

prefLabel

Two phosphAte taRGets in End-s ...... A Randomized Controlled Trial.

@en

Two phosphAte taRGets in End-stage renal disease Trial

@nl

P1476

Two phosphAte taRGets in End-s ...... A Randomized Controlled Trial.

@en

P2093

Andrea Mazzetti

http://www.w3.org/2001/XMLSchema#string

Andrea Rathe-Skafel

http://www.w3.org/2001/XMLSchema#string

Andrew Smyth

http://www.w3.org/2001/XMLSchema#string

Andrew T Yan

http://www.w3.org/2001/XMLSchema#string

Braden J Manns

http://www.w3.org/2001/XMLSchema#string

Christian G Rabbat

http://www.w3.org/2001/XMLSchema#string

Jackie Bosch

http://www.w3.org/2001/XMLSchema#string

Jessica Tyrwhitt

http://www.w3.org/2001/XMLSchema#string

Karthik Tennankore

http://www.w3.org/2001/XMLSchema#string

Louis Girard

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients

Oral phosphate binders in patients with kidney failure

The emerging role of phosphate in vascular calcification.

Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients

Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Phosphorus binders and survival on hemodialysis.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States.

Pathophysiology of vascular calcification in chronic kidney disease.

P304

965-973

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.10941016

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amit X Garg

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28550080

http://www.w3.org/2001/XMLSchema#string

P932

5460712

http://www.w3.org/2001/XMLSchema#string

Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.

about

P2860

P2860

Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932